Advanced Oncotherapy (AVO) – Exercise of warrants and options and issue of shares

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has agreed to issue 7,166,667 new ordinary shares  of 1p in the Company to Dr. Nick Plowman, Chairman of the Medical Advisory Board, pursuant to the exercise of warrants and options at prices between 1.1 pence and 5 pence. […]

Advanced Oncotherapy (AVO) – Exercise of Warrants and issue of Shares

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has today issued 34,122,682 new ordinary shares of 1p in the Company at a price of 1.1 pence per New Share pursuant to the exercise of warrants by Brahma AG. The warrants were issued on 25 September 2013 to […]

Advanced Oncotherapy – Exercise of Warrants and Issue of Shares

Exercise of Warrants and Issue of Shares. Issue of Shares Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that it has today issued 600,000 new ordinary shares of 1p in the Company at a subscription price of 8 pence per Ordinary Share to Dr Enrico Vanni, a non-executive director, […]

Advanced Oncotherapy – Exercise of Warrants and Issue of Shares and Warrants

Exercise of Warrants Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for treating cancer, announces that it has today issued 5,000,000 new ordinary shares at a subscription price of 1 penny each pursuant to the exercise of warrants. Issue of Further Shares and Warrants In accordance with the Supplemental Agreement with Brahma AG […]